Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
Science, AI, and Human Ingenuity Converge to Transform Medical Affairs
Today, we're witnessing an unprecedented convergence of scientific advancement, artificial intelligence (AI) capabilities, and human...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content
In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
Readability of published vs. artificial intelligence (AI)-generated plain-language summaries (PLS)
PLS play an important role in increasing the accessibility of medical publications to a wide...
Use of audiovisual data dissemination formats (ADDFs) by medical journals: then and now
GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...
Digital Publication Extenders: Creating an Ecosystem for a More Engaging and Informative Experience
While creating digital publication extenders may seem complex, Cactus Life Sciences can assist in developing...